Related references
Note: Only part of the references are listed.Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway
Zhang Chao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
Tianke Chen et al.
CELL DEATH & DISEASE (2020)
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth
Brian I. Carr et al.
JOURNAL OF GASTROINTESTINAL CANCER (2020)
Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells
Patricia M. Santos et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Platelets as Key Factors in Hepatocellular Carcinoma
Natasa Pavlovic et al.
CANCERS (2019)
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics
Quirino Lai et al.
CANCERS (2019)
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
Edoardo Giovanni Giannini et al.
HEPATOLOGY (2018)
Identification of -fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
Wei Zhu et al.
HEPATOLOGY (2018)
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
Marianne Ziol et al.
HEPATOLOGY (2018)
The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade
Kuan-Chieh Fang et al.
LIVER CANCER (2018)
Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
Shanshan Wang et al.
CELL DEATH & DISEASE (2018)
The Extended Toronto Criteria for Liver Transplantation in Patients With Hepatocellular Carcinoma: A Prospective Validation Study
Gonzalo Sapisochin et al.
HEPATOLOGY (2016)
Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells
Yan Lu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel
Xiaonan Ji et al.
TUMOR BIOLOGY (2016)
Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells
Mingyue Zhu et al.
ONCOTARGET (2016)
Fifty Years of Discovery of Alpha-Fetoprotein as the First Tumor Marker
Dina Nikulina et al.
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO (2015)
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro
Brian I. Carr et al.
BMC CANCER (2014)
Features of massive hepatocellular carcinomas
Brian I. Carr et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Platelet-Related Phenotypic Patterns in Hepatocellular Carcinoma Patients
Brian I. Carr et al.
SEMINARS IN ONCOLOGY (2014)
Identification of Two Clinical Hepatocellular Carcinoma Patient Phenotypes From Results of Standard Screening Parameters
Brian I. Carr et al.
SEMINARS IN ONCOLOGY (2014)
Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer
Lu Zheng et al.
TUMOR BIOLOGY (2014)
Above 5 cm, Size Does Not Matter Anymore in Patients with Hepatocellular Carcinoma
Chetana Lim et al.
WORLD JOURNAL OF SURGERY (2014)
Significance of platelet and AFP levels and liver function parameters for HCC size and survival
Brian I. Carr et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Value of alpha-fetoprotein and clinical characteristics in patients with liver neoplasm
J. B. Xu et al.
NEOPLASMA (2014)
Hepatocellular Carcinoma Size: Platelets, γ-Glutamyl Transpeptidase, and Alkaline Phosphatase
Brian I. Carr et al.
ONCOLOGY (2013)
Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma
Shanshan Wang et al.
JOURNAL OF HEPATOLOGY (2012)
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
Giovanni Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
α-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells
M. Yamamoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines
Mengsen Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo
Yang Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma
Tohru Utsunomiya et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Solitary Large Hepatocellular Carcinoma A Specific Subtype of Hepatocellular Carcinoma With Good Outcome After Hepatic Resection
Lian-Yue Yang et al.
ANNALS OF SURGERY (2009)
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
TM Pawlik et al.
LIVER TRANSPLANTATION (2005)
Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma
OM Ebied et al.
CANCER (2003)